Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access
Multiple Cleveland Clinic sites to participate in National Cancer Institute trial comparing treatment regimens for newly diagnosed patients
Long-term relationship building and engagement key to gaining community trust
Previous studies, trial aims and the potential role of immunotherapy
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dedicated investigators and clinicians bring expertise in drug development and flexible study design
Breaking through barriers in cancer care
A New Standard of Care in Relapsed/Refractory Large B-Cell Lymphoma
Molecular tumor profiling is available to patients
Recruitment open for Phase III trial of immunotherapy plus chemotherapy and radiotherapy
Underfunding could impact clinical trial development